AUS
NZ
UK
CA
USA
IND
Healthcare
Artrya Ltd Advances in Medical AI with Strong Market Movement
April 24, 2026 02:54 PM AEST| By Team Kalkine MediaArtrya Ltd gains attention as AI-driven cardiac imaging platform Salix enhances clinical workflows, highlighting innovation within Australia’s healthcare and technology sector.
4DMedical’s ASX 200 Momentum: Is Growth Already Priced In?
April 24, 2026 02:44 PM AEST| By Team Kalkine MediaStrong commercial progress and rising attention highlight evolving valuation dynamics, reflecting how innovation and sentiment interact within Australia’s equity landscape and influence future growth expectations.
Why Is (ASX:EBR) Gaining Attention After TGA Fast-Track Path?
April 24, 2026 02:43 PM AEST| By Sam(ASX:EBR) moves closer to Australian approval after securing a faster regulatory pathway, highlighting innovation in wireless cardiac therapy and improved treatment access.
Why Is (ASX:MVP) Gaining Attention as Penthrox Strengthens Cash Flow?
April 24, 2026 02:25 PM AEST| By SamMedical Developments International shows improved cash flow and product demand, with European expansion and regulatory developments shaping future growth across its healthcare portfolio.
ASX Biotech Watch: Can Tetratherix’s Momentum Continue?
April 24, 2026 02:19 PM AEST| By SamTetratherix continues to progress across clinical trials, partnerships, and commercial readiness, highlighting its growing presence in the regenerative medicine and healthcare innovation sector.
Cochlear Outlook Cut Weighs on ASX 200 Healthcare
April 24, 2026 12:08 PM AEST| By SamCochlear’s revised outlook highlights healthcare sector sensitivity, with corporate updates influencing market sentiment and shaping activity across ASX-listed medical technology companies.
ASX 200 Shock Sell-Off: Are These Beaten-Down Stocks Stirring Again?
April 24, 2026 10:41 AM AEST| By Team Kalkine MediaMarket volatility has pressured key ASX stocks, with healthcare names like Cochlear drawing attention as sentiment shifts amid geopolitical uncertainty and evolving global conditions.
What Drives InteliCare’s Move Into Retirement Living?
April 23, 2026 09:35 PM AEST| By SamInteliCare expands into retirement living through a new agreement, highlighting growth opportunities, recurring revenue potential, and key financial and execution challenges in the evolving healthcare technology sector.
ASX Healthcare Sector Focus Within ASX 200 Featuring Select Tickers
April 23, 2026 09:14 PM AEST| By Team Kalkine MediaOverview of the ASX healthcare sector with company highlights, index positioning, and sector dynamics across major Australian indices and related market segments.
What Triggered the Sharp Fall in Cochlear Shares?
April 23, 2026 08:41 PM AEST| By SamCochlear’s recent outlook shift has stirred market reaction, highlighting operational challenges, investor sentiment, and evolving dynamics within Australia’s healthcare stock landscape.
ASX 300 Biotech Stock Completes Capital Raise Move
April 23, 2026 04:00 PM AEST| By SamAn ASX biotech company gains attention after completing a capital raising initiative, supporting ongoing immuno-oncology research and development within Australia’s healthcare sector.
What’s Driving Imugene’s Fresh Capital Push and Market Focus?
April 23, 2026 03:51 PM AEST| By SamImugene strengthens its financial position through a successful capital raise, supporting clinical development and advancing its innovative cancer therapy pipeline amid growing investor interest.
ASX 200 Meltdown: Cochlear’s Record Crash Leaves Investors Reeling
April 23, 2026 03:17 PM AEST| By SamCochlear’s historic share price crash followed a sharp earnings downgrade, erasing billions in value and highlighting growing pressures across the healthcare sector in the Australian share market.
ASX 200 Shockwave: Cochlear Crash Sparks Massive Investor Losses
April 23, 2026 03:15 PM AEST| By SamCochlear’s sharp earnings downgrade triggered a major share price collapse, wiping billions in value and shaking confidence in the ASX healthcare sector amid ongoing global challenges.
ASX 200 Shocker: Cochlear Crash Wipes Out Years of Gains
April 23, 2026 03:11 PM AEST| By SamCochlear’s sharp decline following an earnings downgrade erased significant market value, highlighting volatility in healthcare stocks and shifting investor sentiment across the Australian share market.
ASX 200 Slides as Healthcare Shock Sends Markets on Edge
April 23, 2026 02:47 PM AEST| By SamThe ASX 200 declined as healthcare stocks, including CSL and Cochlear, led a sharp sell-off, while defensive sectors showed resilience amid rising market volatility and shifting investor sentiment.
ASX 200 Healthcare Giant CSL Hits Multi-Year Low—What’s Driving the Slide?
April 23, 2026 02:45 PM AEST| By SamCSL shares fall to multi-year lows as earnings challenges, restructuring plans, and global healthcare shifts drive a reassessment of its growth outlook in the Australian share market.
Warrigal Partnership Positions InteliCare in ASX 200 Aged Care
April 23, 2026 02:16 PM AEST| By Team Kalkine MediaInteliCare expands into retirement living through a Warrigal agreement, deploying monitoring systems across villas and strengthening digital integration in aged care environments.
Why Are CSL Limited (ASX:CSL) and Cochlear (ASX:COH) Influencing ASX 200 Healthcare Stocks?
April 23, 2026 01:57 PM AEST| By SamASX 200 today reflects softer movement as healthcare stocks influence index performance, highlighting sector-driven shifts across the Australian market.
Is ASX All Ordinaries Powering Healthcare Innovation?
April 23, 2026 12:04 PM AEST| By SamHealthcare technology trends within the ASX All Ordinaries highlight digital innovation, global expansion, and evolving market dynamics shaping Australia’s healthcare sector.
Advertise your brand on Kalkine Media